![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028년까지 유럽 분자생물학 효소, 키트 및 시약 시장 예측 – 제품(효소, 키트 및 시약), 응용(후생유전학, 시퀀싱, 합성 생물학, 중합효소 연쇄 반응 및 기타)별 코로나19 영향 및 지역 분석 및 최종 사용자(생명공학 및 제약회사, 병원 및 진단센터, 학술 및 연구기관)
시장 소개
유럽 분자생물학 효소, 키트 & 시약 시장은 독일, 프랑스, 이탈리아, 영국, 스페인 및 기타 유럽 지역으로 구성됩니다. 시장의 성장은 암 질환의 증가와 해당 지역 정부의 투자 증가에 기인합니다. 또한, 증가하는 코로나19 인구로 인해 분자생물학 효소, 키트 및 제품의 성장이 촉진될 가능성이 높습니다. 국내 시약 시장. 나머지 유럽은 러시아, 폴란드, 오스트리아, 스위스, 스웨덴, 노르웨이, 덴마크, 벨기에, 네덜란드 등과 같은 국가로 구성됩니다. 제약 부문은 전통적으로 산업 전체에서 활기차고 혁신을 주도하며 매우 성공적인 구성 요소였습니다. 최근 몇 년 동안 화학, 분자생물학, 유전체학, 화학 기술의 눈부신 발전과 분광학, 크로마토그래피, 결정학 등 동계 분야의 융합으로 인해 광범위한 스펙트럼의 치료를 위한 수많은 새로운 치료제가 발견 및 개발되었습니다. 질병의. 제약 부문의 혁신 척도는 새로운 화학 및 생물학적 기업의 출시 횟수입니다. 지난 수십 년 동안 유럽에서는 연구 부문에서 경쟁이 치열해졌습니다. 연구 및 조사 증가 개발 활동 및 임상 시험, 임상 및 연구 실험실의 수가 증가함에 따라 분자 생물학 효소, 키트 및 제품에 대한 수요가 증가했습니다. 시약 시장.
이탈리아, 스페인, 영국, 독일, 프랑스와 러시아, 스위스 등 여러 유럽 국가가 큰 영향을 받았습니다. 유럽 경제는 이 지역의 코로나19 사례가 기하급수적으로 증가하면서 심각한 영향을 받고 있습니다. 스페인, 이탈리아, 독일, 프랑스, 영국은 유럽 국가 중 가장 큰 영향을 받았으며 사망자 수도 많았습니다. 국제 보건 규정에 따라 세계보건기구(WHO)는 코로나19 발병을 국제적 공중보건 비상사태로 선포했습니다. 2020년 제품 출시 횟수 증가와 코로나19 발병률 증가는 유럽 분자생물학 효소, 키트 및 제품에 긍정적인 영향을 미쳤습니다. 시약 시장. 2020년 유럽의약품청(EMA)은 약 97개 의약품에 대한 시판 허가를 승인했으며, 그 중 39개는 신약이다. 마찬가지로, 2020년 10월 Eurofins는 유럽에서 재택 자가 샘플링 옵션을 갖춘 코로나19 PCR 테스트를 도입했습니다.
시장 개요 및 역학
유럽의 분자 생물학 효소, 키트 및 시약 시장은 2021년 41억 2,528만 달러에서 미국 달러로 성장할 것으로 예상됩니다. 2028년까지 12,561,600,000명; 2021년부터 2028년까지 CAGR 17.2%로 성장할 것으로 예상됩니다. 새로운 암 진단 솔루션의 출현과 함께 감염성 질환을 탐지하기 위한 분자 진단 절차의 채택 증가는 분자생물학 효소, 키트 및 시약 시장을 지원할 가능성이 높습니다. 예측 기간 동안의 성장. 분자진단 검사는 DNA나 RNA의 특정 서열 사이의 교란을 탐지하는 데 사용됩니다. 단일염기다형성(SNP), 결실, 재배열, 삽입 등의 불규칙성은 감염성 질환, 암, 바이러스성 질환, 성병(STD) 등 다양한 질병을 유발합니다. 이러한 높은 감염병 유병률과 암 발생률의 증가로 인해 분자진단은 특이도가 높은 질병을 진단할 수 있어 정밀의학으로 환자를 치료할 수 있는 기반을 마련함으로써 분자진단에 대한 관심이 높아지고 있습니다. 다양한 정부에서는 정밀의학 분야의 연구개발에 주력하고 있습니다. 따라서 분자 진단에 대한 관심이 높아지는 것은 분자생물학 효소, 키트, 시약 시장 참여자에게 중요한 기회로 떠오르고 있습니다.
주요 시장 부문
유럽 분자 생물학 효소, 키트 및 시약 시장은 제품, 응용 프로그램, 최종 사용자 및 국가로 분류됩니다. 제품을 기준으로 분자 생물학 효소, 키트 및 시약 시장은 효소와 키트 & 시약. 시장은 효소에 따라 중합효소, 리가아제, 역전사효소, 포스파타아제, 프로테아제 및 단백질분해효소, 제한 엔도뉴클레아제 등으로 더욱 세분화됩니다. 키트 & 시약 부문은 2020년에 더 큰 시장 점유율을 차지했습니다. 분자 생물학 효소, 키트 및 시약 시장은 응용 분야에 따라 후생유전학, 시퀀싱, 합성 생물학, 중합효소 연쇄 반응 등으로 분류됩니다. 2020년에는 시퀀싱 부문이 가장 큰 시장 점유율을 차지했습니다. 최종 사용자 측면에서 분자 생물학 효소, 키트 및 시약 시장은 생명공학 및 제약 회사, 병원 및 진단 센터, 학술 및 연구 기관으로 분류됩니다. 생명공학 및 제약 회사 부문은 2020년 시장에서 가장 큰 점유율을 차지했습니다. 국가를 기준으로 유럽 분자 생물학 효소, 키트 및 시약 시장은 프랑스, 독일, 이탈리아, 스페인, 영국 및 기타 유럽으로 분류됩니다. 나머지 유럽 지역은 2020년에 가장 큰 시장 점유율을 차지했습니다.
주요 출처 및 회사 목록
몇 가지 주요 주요 기업 유럽의 분자생물학 효소, 키트 및 시약 시장에 대한 이 보고서를 준비하기 위해 참조된 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서 및 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 Agilent Technologies, Inc.입니다. F. HOFFMANN-LA ROCHE LTD; 일루미나, Inc.; 머크 KGAA; 메리디안 바이오사이언스, INC; 프로메가 코퍼레이션; 퀴아겐; Rockland Immunochemicals Inc; 및 THERMO FISHER SCIENTIFIC INC.
구매 이유 보고서
- 유럽의 분자 생물학 효소, 키트 및 시약 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별합니다.
- 유럽 분자 생물학 효소, 키트 및 시약 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
- 유럽 분자 생물학 분야에서 M&A 및 파트너십 거래를 효율적으로 계획하세요. 가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 효소, 키트 및 시약 시장을 조사합니다.
- 유럽 분자 생물학 효소, 키트, 및 시약 시장.
- 2021~2028년 유럽 지역의 다양한 부문별 시장 수익 예측을 알아보세요.
유럽 분자 생물학 효소, 키트 및 시약 시장 세분화
유럽 분자 생물학 효소, 키트 및 시약 시장 - 제품별
- 효소
- 중합효소
- 접합효소
- 역전사효소
- 인산분해효소
- 프로테아제 및 단백질분해효소
- 제한 엔도뉴클레아제
- 기타
- 키트 및 시약
유럽 분자 생물학 효소, 키트 및 시약 시장 - 작성자 응용
- 후생유전학
- 서열 분석
- 합성 생물학
- 중합효소 연쇄 반응
- li>
- 기타
유럽 분자 생물학 효소, 키트 및 시약 시장 - 최종 사용자별
< ul>유럽 분자 생물학 효소, 키트 및 시약 시장 - 국가별
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 유럽 나머지 지역
유럽 분자 생물학 효소, 키트 및 시약 시장 - 회사 프로필
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Product
1.3.2 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Application
1.3.3 Europe Molecular Biology Enzymes, Kits & Reagents Market – By End-User
1.3.4 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Country
2. Europe Molecular Biology Enzymes, Kits & Reagents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Molecular Biology Enzymes, Kits & Reagents Market – Market Landscape
4.1 Europe PEST Analysis
4.1.1 Expert Opinion
5. Europe Molecular Biology Enzymes, Kits & Reagents Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Genomics Getting Financial Assistance
5.1.2 Sequencing Procedures Becoming Cheaper
5.1.3 Chronic Diseases Becoming More Prevalent
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Surge in Acceptance of Molecular Diagnostics
5.4 Future Trends
5.4.1 Personalized Medicines at Huge Demand
5.5 Impact analysis
6. Molecular Biology Enzymes, Kits & Reagents Market – Europe Analysis
6.1 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Forecast and Analysis
7. Europe Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Product
7.1 Overview
7.2 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Polymerases
7.3.3.1 Overview
7.3.3.2 Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Ligase
7.3.4.1 Overview
7.3.4.2 Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Reverse Transcriptases
7.3.5.1 Overview
7.3.5.2 Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Phosphatases
7.3.6.1 Overview
7.3.6.2 Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 Proteases and Proteinases
7.3.7.1 Overview
7.3.7.2 Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Restriction Endonuclease
7.3.8.1 Overview
7.3.8.2 Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.9 Other
7.3.9.1 Overview
7.3.9.2 Other: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Kits and Reagents
7.4.1 Overview
7.4.2 Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Application
8.1 Overview
8.2 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sequencing
8.4.1 Overview
8.4.2 Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Synthetic Biology
8.5.1 Overview
8.5.2 Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Epigenetics
8.6.1 Overview
8.6.2 Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Molecular Biology Enzymes, Kits & Reagents Market – By End User
9.1 Overview
9.2 Europe Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
9.3 Biotechnological and Pharmaceutical Companies
9.3.1 Overview
9.3.2 Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Diagnostic Centers
9.4.1 Overview
9.4.2 Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Molecular Biology Enzymes, Kits & Reagents Market – Country Analysis
10.1 Overview
10.1.1 Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
10.1.1.1 Germany
10.1.1.1.1 Germany: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.1.3 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.1.4 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.1.5 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.2 France
10.1.1.2.1 France: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 France: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.2.3 France: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.2.4 France: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.2.5 France: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.3 United Kingdom
10.1.1.3.1 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.3.3 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.3.4 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.3.5 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.4 Italy
10.1.1.4.1 Italy: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.4.3 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.4.4 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.4.5 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.5 Spain
10.1.1.5.1 Spain: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.2 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.5.3 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.5.4 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.5.5 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.6 Rest of Europe
10.1.1.6.1 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.2 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.6.3 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.6.4 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.6.5 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Molecular Biology Enzymes, Kits & Reagents Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Molecular Biology Enzymes, Kits & Reagents Market Industry Landscape
12.1 Overview
12.2 Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.2 Recent Organic Developments in the Molecular Biology Enzymes, Kits & Reagents Market
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Illumina, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 QIAGEN
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Agilent Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Jena Bioscience GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERIDIAN BIOSCIENCE, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Promega Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. France: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 6. France: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 7. France: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. France: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 10. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 11. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 14. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 15. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 18. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 19. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Recent Inorganic Developments In The Molecular Biology Enzymes, Kits & Reagents Market
Table 26. Glossary of Terms, Molecular Biology Enzymes, Kits & Reagents Market
LIST OF FIGURES
Figure 1. Europe Molecular Biology Enzymes, Kits & Reagents Market Segmentation
Figure 2. Europe Molecular Biology Enzymes, Kits & Reagents Market Segmentation, By Country
Figure 3. Europe Molecular Biology Enzymes, Kits & Reagents Market Overview
Figure 4. Kits and Reagents Segment Held Largest Share of Europe Molecular Biology Enzymes, Kits & Reagents Market
Figure 5. UK to Show Remarkable Growth During Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Europe Molecular Biology Enzymes, Kits, and Reagents Market Impact Analysis of Driver and Restraints
Figure 8. Europe Molecular Biology Enzymes, Kits & Reagents Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
Figure 10. Europe Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Europe Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
Figure 20. Europe Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
Figure 26. Europe Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Academic and Research Institute: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
Figure 31. Germany: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. France: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Italy: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Spain: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in European Country Markets
Figure 38. Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe molecular biology enzymes, kits, and reagents market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe molecular biology enzymes, kits, and reagents market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the molecular biology enzymes, kits, and reagents market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution